Hobscheid, Luxembourg

Mélanie Vausort

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Inventor Mélanie Vausort

Introduction

Mélanie Vausort is a notable inventor based in Hobscheid, Luxembourg. He has made significant contributions to the field of medical research, particularly in the area of heart failure. His innovative work has led to the development of new biomarkers that can aid in the prediction and diagnosis of heart failure.

Latest Patents

Mélanie Vausort holds one patent titled "Biomarkers for heart failure." This patent discloses circular RNAs (circRNAs) as new biomarkers for the development of heart failure following myocardial infarction. The application provides methods for predicting and diagnosing heart failure based on the measurement of one or more circRNAs. Additionally, it includes kits and devices designed for measuring these circRNAs and performing the associated methods. The patent also outlines methods for treating patients at risk of heart failure based on the evaluation of these circRNAs.

Career Highlights

Mélanie Vausort is affiliated with the Luxembourg Institute of Health (LIH), where he conducts his research. His work has been instrumental in advancing the understanding of heart failure and developing innovative diagnostic tools. His contributions have the potential to significantly impact patient care and treatment outcomes.

Collaborations

Mélanie has collaborated with esteemed colleagues such as Yvan Devaux and Lu Zhang. These partnerships have fostered a collaborative environment that enhances the research and development of new medical technologies.

Conclusion

Mélanie Vausort's innovative work in identifying biomarkers for heart failure represents a significant advancement in medical research. His contributions are paving the way for improved diagnostic and treatment methods for patients at risk of heart failure.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…